A fight worth fighting?

A fight worth fighting?

As we have been stating things are getting increasingly wacky in this world of ours. First comes rumors of Medtronic (NYSE: MDT) buying LifeScan from Johnson and Johnson (NYSE: JNJ). Now the rumor mill is circulating around our friends at Tandem (NASDAQ: TNDM), who without some serious help will cease to exist. The latest rumor is that a private equity group wants to buy the company, take it private and pour so money into the company. Now before we go any further let us add our standard disclaimer that this may not happen at all . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.